Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine

By Baryalei M.   Zenker D.   Pieske B.   Tondo K.   Dalichau H.   Aleksic I.  

Transplantation Proceedings, Vol. 35, Iss. 4, 2003-06 ,pp. : 1539-1542

Elsevier

Access to resources Recommend Favorite

Daclizumab induction as an immunosuppressive regimen for renal transplant recipients from non-heart-beating donors

By Sanchez-Fructuoso A.I.   Prats D.   Marques M.   Ridao N.   Conesa J.   Garcia Mena M.   Torrente J.   Barrientos A.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1689-1690

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors over 55 years of age

By Gentil M.A.   Osuna A.   Capdevila L.   Rodriguez-Algarra G.   Cantarell C.   Pereira P.   Gonzalez-Molina M.   Spanish Kidney Transplant of Elderly Donor Study Group  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1706-1708

Elsevier

Access to resources Recommend Favorite

Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish group

By Puig i Mar J.M.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2256-2258

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of treatment with low-dose Fluvastatin in hypercholesterolemic renal transplant recipients

By Akiyama T.   Ishii T.   Imanishi M.   Nishioka T.   Matsuura T.   Kurita T.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2115-2118

Elsevier

Access to resources Recommend Favorite